Vical Inc.

Company Website

10390 Pacific Center Ct.
San Diego, CA 92121

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Vical Inc.

Market Cap as of 6/12/2015

$134,421,888

Market Cap as of 7/03/2014

Market Cap as of 07/02/2013

$285,279,022

Market Cap as of 06/26/2012

$287,839,630

Market Cap as of 01/04/2012

$307,656,600

Market Cap as of 06/20/2011

$291,159,300

Market Cap as of 01/06/2011

$152,558,200

Exchange and Ticker Symbol

Nasdaq: VICL

Fields of Research

Research and development of biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of serious or life-threatening diseases

Major Products

Allovectin; CyMVectin; and therapeutic and prophylactic vaccines for herpes simplex type 2 virus

View all the companies in San Diego Publicly Traded Companies

Vical Inc.

Market Cap as of 6/12/2015

Exchange

NASDAQ GM

Ticker

VICL

Executives

Vijay Samant (profile)

  • Chief Executive Officer
  • President